Back

Newly diagnosed heart failure in patients with atrial fibrillation referred for catheter ablation - identifying patients with arrhythmia-induced cardiomyopathy

7 April 2024 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: heart failure Heart Failure in Atrial Fibrillation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jan Riess

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

7 More presentations in this session

Presentation thumbnail
Single center experience of efficacy and safety of atrioventricular node ablation after left bundle branch area pacing for the management of atrial fibrillation
Doctor M. Jacobs (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Improvement in atrial functional and ventricular functional tricuspid regurgitation following catheter ablation or cardioversion of atrial fibrillation
Doctor B. Kuru Gorgulu (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Stroke after implantable cardioverter-defibrillator shocks in patients with heart failure
Mr M. Dyrbus (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Definition and management of arrhythmia-induced cardiomyopathy: findings from the EHRA SIC survey
Associate Professor P. Badertscher (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation
Mrs R. Arnet (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: heart failure

The Event

Event poster

EHRA 2024

7 April 2024 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Arrhythmia-induced cardiomyopathy: clinical and echocardiographic characteristics compared to idiopathic dilated cardiomyopathy
thumbnail
Congress Presentation
Putting it all together: the role of occult arrhythmia-induced cardiomyopathy in atrial fibrillation and HFrEF
thumbnail
Congress Presentation
Comparative changes in echocardiographic parameters and NT-proBNP levels after catheter ablation in patients with HF and persistent AF across HF phenotypes